NFKB1 and breast cancer: Yang et al. [112] found that resveratrol and cisplatin synergistically reduce the viability, migration, and invasion of MDA-231 breast cancer cells by regulating EMT, PI3K/AKT, Smad, NF-κB, JNK, and ERK expression in tumor tissue.